UNICEL® DXC 800 SYNCHRON® SYSTEM
Report
- Report Number
- 2050012-2011-04480
- Event Type
- Malfunction
- Date Received
- August 17, 2011
- Date of Event
- July 27, 2011
- Report Date
- July 27, 2011
- Manufacturer
- BECKMAN COULTER, INC.
- Product Code
- JJE
- PMA / PMN Number
- K042291
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- PA, US
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
Narratives
SERVICE WAS DISPATCHED TO THE SITE FOR THIS EVENT. THE FIELD SERVICE ENGINEER REPLACED ALL OF THE TUBING ON THE PHOSM MODULE AND PERFORMED LAMP CALIBRATION TO RESOLVE THE ISSUE. ALTHOUGH THE INSTRUMENT WAS REPAIRED PRIOR TO RETURNING THE INSTRUMENT BACK INTO SERVICE, A DEFINITIVE ROOT CAUSE IS UNKNOWN AT THIS TIME.
A CUSTOMER REPORTED THAT ON (B)(6) 2011 ERRATIC PHOSPHORUS (PHOSM) RESULTS WERE GENERATED ON A UNICEL DXC 800 SYNCHRON SYSTEM FOR ONE PATIENT SAMPLE. DATA PROVIDED BY THE CUSTOMER INDICATES THAT THE INITIAL RESULT WAS REPEATED ON THE SAME INSTRUMENT IN DUPLICATE. REPEAT RESULTS WERE DIFFERENT FROM THE INITIAL RESULT, AND EACH OTHER. THE ERRATIC RESULTS WERE NOT REPORTED OUT OF THE LABORATORY AND HENCE THERE WAS NO DEATH, SERIOUS INJURY OR MODIFICATION TO PATIENT TREATMENT ASSOCIATED OR ATTRIBUTED TO THIS EVENT. DATA PROVIDED BY THE CUSTOMER ALSO DEMONSTRATED THAT 5 ADDITIONAL PHOSPHORUS RESULTS, FOR DIFFERENT PATIENTS, WERE GENERATED ON THE UNICEL DXC 800 SYNCHRON SYSTEM AND CONFIRMED AS VALID BY A REPEAT TEST PERFORMED ON ANOTHER INSTRUMENT. THESE RESULTS WERE NOT REGARDED AS ERRATIC. THE INSTRUMENT PHOSPHORUS QUALITY CONTROL (QC) RESULTS DID NOT RECOVER WITHIN THE CUSTOMER'S ESTABLISHED SPECIFICATIONS THE DAY PRIOR TO THE EVENT. ADDITIONALLY, INSTRUMENT QC WARNINGS WERE GENERATED THE DAY PRIOR TO THE EVENT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | UNICEL® DXC 800 SYNCHRON® SYSTEM | ANALYZER, CHEMISTRY | JJE | BECKMAN COULTER, INC. | NA | NA |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 78 YR |